Drug Profile
Scutellariae radix
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 13 Jul 1999 New profile
- 13 Jul 1999 Preclinical development for Cancer in Japan (Unknown route)